Ennis & Ennis, P.A.

Ennis & Ennis, P.A. reports that in the first Actos bladder cancer case to be tried, the jury awarded plaintiff, Jack Cooper, $6.5 million in damages against Actos manufacturer, Takeda Pharmaceutical of Japan

Ennis & Ennis, P.A. reports that the judge in the second Fosamax femur fracture trial made several important rulings, which could have important implications in the outcome of the trial.

Ennis & Ennis, P.A. reports that the FDA is warning of the dangers of DMAA and is working to ensure that any dietary supplements containing the stimulant, dimethylamylamine (DMAA) will no longer be distributed or sold in the U.S. marketplace.

Ennis & Ennis, P.A. reports that the second trial alleging that osteoporosis drug Fosamax caused a femur fracture began this week before U.S. District Judge Joel Pisano in Trenton, New Jersey.

Actos manufacturer, Takeda is fully embroiled in the first of over 3,000 Actos lawsuits to go to trial claiming the diabetes drug causes bladder cancer.

The nation’s first trial involving claims that Fosamax caused femur fractures began this week in New Jersey Superior Court, Atlantic County. According to the Plaintiff, Christina Su, Merck& Co.

Ennis & Ennis, P.A. reports on the Punitive Damage Award against J&J in the first transvaginal mesh lawsuit.

Ennis & Ennis, P.A. reports on the trial and verdict in the first Ethicon transvaginal mesh lawsuit.

U.S. based Affymax, Inc., and Takeda Pharmaceutical Co., Japan’s biggest drug manufacturer, voluntarily recalled all lots of an anemia treatment for kidney dialysis patients called Omontys after reports of injuries and death.

The first trial of many lawsuits alleging that diabetes medication Actos causes bladder cancer is scheduled to begin this week in Los Angeles.